RCEL
Avita Medical LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$133.26M
P/E Ratio
—
EPS
$-1.74
Beta
1.89
52W High
$9.85
52W Low
$3.22
50-Day MA
$4.53
200-Day MA
$4.44
Dividend Yield
—
Profit Margin
-67.80%
Forward P/E
10.83
PEG Ratio
—
About Avita Medical Ltd
AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.
Fundamentals
| Revenue (TTM) | $71.61M |
| Gross Profit (TTM) | $58.82M |
| EBITDA | $-40.24M |
| Operating Margin | -59.10% |
| Return on Equity | -1746.00% |
| Return on Assets | -39.10% |
| Revenue/Share (TTM) | $2.57 |
| Book Value | $-0.55 |
| Price-to-Book | 11.77 |
| Price-to-Sales (TTM) | 1.86 |
| EV/Revenue | 2.349 |
| EV/EBITDA | -6.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -4.30% |
| Shares Outstanding | $30.78M |
| Float | $30.28M |
| % Insiders | 0.96% |
| % Institutions | 15.94% |
Historical Volatility
HV 10-Day
65.39%
HV 20-Day
92.84%
HV 30-Day
83.20%
HV 60-Day
80.36%
HV Rank
56.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.59 target)
3
Buy1
HoldData last updated: 4/29/2026